Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00902382 · ClinicalTrials.gov registry record
Registry of Pregnancies Conceived Following Exposure to Ovulation Stimulation Medications
A clinical trial, sponsored by Yale University.
- Completed
- Registry status
- 264
- Enrollment target
NCT00902382: Completed study, sponsored by Yale University.
NCT00902382 is a clinical trial that has completed, run by Yale University. The registered enrollment target is 264 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00902382 has completed, sponsored by Yale University.
- COMPLETED
- Registry status
- 264 participants
- Enrollment target
Study Summary
To identify adverse effects of ovulation drugs on pregnancy, including pregnancy loss, fetal teratology and dysmorphology, and infant development up to age 3.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 264 participants |
| Start Date | 2009-05 |
| Est. Completion | 2014-06-27 |
What the finished NCT00902382 record still lists
NCT00902382 is an observational study that tracks outcomes without assigning an intervention. The registered 264 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT00902382 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00902382 about?
NCT00902382 is a clinical study titled "Registry of Pregnancies Conceived Following Exposure to Ovulation Stimulation Medications". To identify adverse effects of ovulation drugs on pregnancy, including pregnancy loss, fetal teratology and dysmorphology, and infant development up to age 3.
What is the current status of trial NCT00902382?
This trial is currently completed. The enrollment target is 264 participants. The study started on 2009-05. Estimated completion is 2014-06-27.
Who is sponsoring clinical trial NCT00902382?
This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04101669 · 264 participants · NA
RESET System Pivotal Trial (Rev F)
- NCT04295863 · 264 participants · Phase 1
Comparing Dosing Intervals of Nivolumab or Pembrolizumab in Locally Advanced or Metastatic Cancers
- NCT05220202 · 264 participants · NA
MOTIVATE to Improve Outcomes for Older Veterans With Musculoskeletal Pain and Depression
- NCT05473013 · 264 participants · NA
Optimizing Digital Health Technology Interventions to Increase Skill Acquisition and Utilization
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia